Stockscreener 앱 받기
0.4175
11.57%
0.0433
시간 외 거래:
.41
-0.0075
-1.80%
Beyond Air Inc 주식(XAIR)의 최신 뉴스
Beyond Air Up 15%, Insiders Still Down After US$1.60m Purchase - Simply Wall St
Smith & Nephew (SNN) Stock Surges Amid Strong Financial Performa - GuruFocus.com
Financial Survey: Beyond Air (NASDAQ:XAIR) versus Perspective Therapeutics (NYSE:CATX) - Defense World
Insider Stock Buying Reaches US$1.60m On Beyond Air - Yahoo Finance
Does Beyond Air Inc (NASDAQ: XAIR) Still Need To Convince Analysts? - Stocks Register
Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - The Manila Times
Beyond Air CEO to Present at Lytham Partners 2025 Healthcare Investor Summit - StockTitan
State Street Corp Sells 53,700 Shares of Beyond Air, Inc. (NASDAQ:XAIR) - Defense World
Inhaled Nitric Oxide Delivery Systems Market Size to Hit USD 562.47 Bn by 2034 - Precedence Research
Beyond Air replaces auditor, cites no disagreements - Investing.com
Beyond Air's SWOT analysis: LungFit PH maker faces cash burn as stock seeks lift - Investing.com
CBS Releases First Look for New Daytime Soap Opera ‘Beyond the Gates’ (TV News Roundup) - Variety
Bears are Losing Control Over Beyond Air (XAIR), Here's Why It's a 'Buy' Now - MSN
Beyond Air's SWOT analysis: LungFit PH stock faces cash burn challenges - Investing.com
National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products - The Manila Times
National Advertising Division Recommends Beyond Air - GlobeNewswire
National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products - GlobeNewswire Inc.
LungFit PH receives European CE mark approval to treat newborns - Pulmonary Hypertension News
Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy - The Manila Times
Beyond Cancer Gets Green Light for Novel Cancer Immunotherapy Trial in Israel | XAIR Stock News - StockTitan
Beyond Air’s LungFit PH system gains European CE mark approval - Yahoo Finance
XAIR (Beyond Air) Shares Outstanding (EOP) : 72.19 Mil (As of Sep. 2024) - GuruFocus.com
Beyond Air Receives CE Mark in Europe for the LungFit® PH System - The Manila Times
Beyond Air Secures EU Approval for Breakthrough Nitric Oxide System, Unlocks $1M Milestone - StockTitan
Beyond Air (STU:48L) Shares Outstanding (EOP) : 72.19 Mil (As of Sep. 2024) - GuruFocus.com
Medical Device Player Beyond Air's Subsidiary Reveals Encouraging Data From Early-Stage Cancer Study - MSN
Discover Air Tahiti Nui's 'Tahitian Dreamliners' Connecting Bora Bora And Beyond - Simple Flying
Beyond Air expands stock option plan and authorizes shares By Investing.com - Investing.com Canada
Beyond Air expands stock option plan and authorizes shares - Investing.com India
Beyond Air Approves Key Changes at Annual Meeting - TipRanks
NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board - The Manila Times
Nobel Laureate Roger Kornberg Joins NeuroNOS Advisory Board to Advance Autism Research - StockTitan
AiAdvertising Appoints Douglas Beck, CPA, as Chief Financial Officer - citybiz
AiAdvertising Announces CFO Transition in Preparation for Nasdaq Uplisting - Business Wire
AiAdvertising Appoints Douglas Beck as New CFO - TipRanks
32 Rules for Flying Now - Bloomberg
Beyond Air, Inc. (XAIR) Reports Q2 Loss, Lags Revenue Estimates - MSN
Beyond Air Stock Slides After Q2 Earnings Beat, Retail’s Confident - MSN
Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Rocket Lab USA, Inc. (RKLB) Reports Q3 Loss, Tops Revenue Estimates - MSN
Beyond Air Reports Increased Revenue Amid Financial Challenges - TipRanks
Big Yellow Group downgraded to Hold from Buy at Jefferies - MSN
Beyond Air Inc (XAIR) Quarterly 10-Q Report - Quartz
Beyond Air, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com
Beyond Air, Inc. (NASDAQ:XAIR) Q2 2025 Earnings Call Transcript - Insider Monkey
Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
Beyond Air earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Beyond Air (XAIR) Reports 60% Hospital Contract Growth, Secures $20.6M Funding | XAIR Stock News - StockTitan
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting - Markets Insider
Beyond Cancer Presents Promising Preclinical Data on Low - GlobeNewswire
0.25%
0.57%
자본화:
|
볼륨(24시간):